Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Nov;86(3):677–684. doi: 10.1111/j.1476-5381.1985.tb08945.x

Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa.

J J Reeves, R Stables
PMCID: PMC1916721  PMID: 2998524

Abstract

The effects of the cyclo-oxygenase inhibitors indomethacin and piroxicam have been investigated on histamine- and dibutyryl cyclic AMP-induced acid secretion in the rat isolated gastric mucosa. The relative potencies of a number of prostanoids as inhibitors of histamine-induced acid secretion were determined in an attempt to classify the prostaglandin receptor mediating this response. Indomethacin (8 X 10(-9) - 2.7 X 10(-6) M) and piroxicam (3 X 10(-6) M) potentiated the secretory responses elicited by histamine. This effect might be due to inhibition of the biosynthesis of antisecretory prostanoids. Indomethacin (2.7 X 10(-6) M) and piroxicam (3 X 10(-6) M) also potentiated the secretory response to dibutyryl cyclic AMP, but since prostaglandin E2 (PGE2, 10(-5) M) did not inhibit this secretory response, the mechanism of the potentiation may differ from that of histamine. The potency of the thromboxane mimetic U-46619 as an inhibitor of histamine-induced acid secretion was markedly reduced in the presence of indomethacin, suggesting that U-46619 may release endogenous antisecretory prostanoids. In the presence of indomethacin (2.7 X 10(-6) M) all the prostanoids tested produced concentration-related inhibitions of histamine-induced gastric acid secretion. PGE-analogues were the most potent compounds, the rank order of potency being 16, 16 dimethyl PGE2 greater than PGE2 greater than PGF2 alpha greater than U-46619 greater than PGD2 greater than PGI2. This order of potency is very similar to that obtained in smooth muscle preparations containing 'EP' receptors, suggesting that this receptor type also mediates inhibition of histamine-induced acid secretion in the rat.

Full text

PDF
677

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anis N. A., Berry S. C., Burton N. R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol. 1983 Jun;79(2):565–575. doi: 10.1111/j.1476-5381.1983.tb11031.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beatty C. H., Bocek R. M., Young M. K., Novy M. J. Effect of Indomethacin on cyclic AMP phosphodiesterase activity in myometrium from pregnant rhesus monkeys. Prostaglandins. 1976 Apr;11(4):713–725. doi: 10.1016/0090-6980(76)90071-x. [DOI] [PubMed] [Google Scholar]
  3. Boughton-Smith N. K., Whittle B. J. Stimulation and inhibition of prostacyclin formation in the gastric mucosa and ileum in vitro by anti-inflammatory agents. Br J Pharmacol. 1983 Jan;78(1):173–180. doi: 10.1111/j.1476-5381.1983.tb09378.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boughton-Smith N. K., Whittle B. J. The gastric antisecretory actions of prostaglandin E2 and stable prostacyclin analogues against different secretagogues in perfused whole-stomachs of rat or mouse in vitro. Br J Pharmacol. 1981 Feb;72(2):291–298. doi: 10.1111/j.1476-5381.1981.tb09128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coceani F., Pace-Asciak C., Volta F., Wolfe L. S. Effect of nerve stimulation on prostaglandin formation and release from the rat stomach. Am J Physiol. 1967 Oct;213(4):1056–1064. doi: 10.1152/ajplegacy.1967.213.4.1056. [DOI] [PubMed] [Google Scholar]
  6. Egg D. Effects of glycosaminoglycan-polysulfate and two non-steroidal anti-inflammatory drugs on prostaglandin E2 synthesis in Chinese hamster ovary cell cultures. Pharmacol Res Commun. 1983 Sep;15(8):709–717. doi: 10.1016/s0031-6989(83)80001-0. [DOI] [PubMed] [Google Scholar]
  7. Frame M. H., Main I. H. Effects of arachidonic acid on rat gastric acid secretion in response to different secretogogues; inhibition of these effects by indomethacin. Br J Pharmacol. 1980 Jun;69(2):171–178. doi: 10.1111/j.1476-5381.1980.tb07887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karim S. M., Carter D. C., Bhana D., Ganesan P. A. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion. Br Med J. 1973 Jan 20;1(5846):143–146. doi: 10.1136/bmj.1.5846.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kennedy I., Coleman R. A., Humphrey P. P., Levy G. P., Lumley P. Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins. 1982 Nov;24(5):667–689. doi: 10.1016/0090-6980(82)90036-3. [DOI] [PubMed] [Google Scholar]
  10. Konturek S. J., Kwiecień N., Swierczek J., Oleksy J., Sito E., Robert A. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology. 1976 May;70(5 PT1):683–687. [PubMed] [Google Scholar]
  11. Main I. H., Whittle B. J. Prostaglandin E2 and the stimulation of rat gastric acid secretion by dibutyryl cyclic 3',5'-AMP. Eur J Pharmacol. 1974 May;26(2):204–211. doi: 10.1016/0014-2999(74)90229-5. [DOI] [PubMed] [Google Scholar]
  12. Major J. S., Scholes P. The localization of a histamine H2-receptor adenylate cyclase system in canine parietal cells and its inhibition by prostaglandins. Agents Actions. 1978 Jun;8(4):324–331. doi: 10.1007/BF01968611. [DOI] [PubMed] [Google Scholar]
  13. Robert A., Nezamis J. E., Phillips J. P. Inhibition of gastric secretion by prostaglandins. Am J Dig Dis. 1967 Oct;12(10):1073–1076. doi: 10.1007/BF02233268. [DOI] [PubMed] [Google Scholar]
  14. Silvola J., Kangasaho M., Tokola O., Vapaatalo H. Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity. Agents Actions. 1982 Oct;12(4):516–520. doi: 10.1007/BF01965936. [DOI] [PubMed] [Google Scholar]
  15. Singh J. Prostaglandin release from rat stomach following vagal stimulation or administration of acetylcholine. Eur J Pharmacol. 1980 Jul 11;65(1):39–48. doi: 10.1016/0014-2999(80)90206-x. [DOI] [PubMed] [Google Scholar]
  16. Skoglund M. L., Nies A. S., Gerber J. G. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins. J Pharmacol Exp Ther. 1982 Feb;220(2):371–374. [PubMed] [Google Scholar]
  17. Soll A. H. Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells. J Clin Invest. 1980 May;65(5):1222–1229. doi: 10.1172/JCI109777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R., Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 1976 Dec;12(6):915–928. doi: 10.1016/0090-6980(76)90126-x. [DOI] [PubMed] [Google Scholar]
  19. Whittle B. J., Boughton-Smith N. K., Moncada S., Vane J. R. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro. Prostaglandins. 1978 Jun;15(6):955–967. doi: 10.1016/0090-6980(78)90038-2. [DOI] [PubMed] [Google Scholar]
  20. Wiseman E. H., Chang Y. H., Lombardino J. G. Piroxicam, a novel anti-inflammatory agent. Arzneimittelforschung. 1976;26(7):1300–1303. doi: 10.1002/chin.197641380. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES